बायोकैमिस्ट्री और फार्माकोलॉजी: ओपन एक्सेस
खुला एक्सेस

अमूर्त

Synthesis of anti-breast cancer complex for breast cancer therapy

Abdul-Wahab R. Hamad

Cancer is a disease of striking significance in the world today. It is the second leading cause of death in the world after cardiovascular diseases and it is projected to beginning the primary cause of death within the coming years. So, scientists and researchers are expanding their research to find the right drug for this deadly disease and find medicine for the treatment of cancer patients because it is a humanitarian issue. Most studies were used chemical complex therapy for cancer, caused degenerated cancer and healthy cells. While, our studies will be prepare chemical and immunotherapy for cancer will be degenerated cancer cells and generated healthy cells. The goal of chemical synthesis complex study is to make a particular product that can be used as chemotherapy, biological and immunotherapy. Firstly, Cu (I), and vitamins are synthesizing and test in laboratory with human breast cancer cell lines. Secondly, the complex will be studied for toxicity, therapeutic dose. All these studies will be in vitro (in laboratory). Thirdly, investigations of the chemical, biological and immunological complex will be study in vivo (animals). The affecting of Cu-complex on animal’s breast cancer cells without impact on other cancer cells. This complex is giving us a hope to use it as a pharmaceutical drug against cancer. We expected that the Copper - complex may serve as a novel chemical restoring agent in cancer tumours and degenerated cancer cells while it generated normal cells in their structure and functions. However, in vitro trials are required more evaluation of this complex in humans.